Insight

Optimizing routes-to-market to accelerate COVID-19 recovery

The COVID-19 disruption presents a unique and pressing opportunity for technology companies to re-evaluate their indirect-direct sales mix

Jorgen Ericsson

Jorgen Ericsson

Principal, TMT Strategy, KPMG US

+1 408-367-1529

Per Edin

Per Edin

Principal, TMT Strategy, KPMG US

+1 408-367-6080

Tucker Serenbetz

Tucker Serenbetz

Director, Corporate Strategy, KPMG US

+1 415-963-7998

Peter Kuck

Peter Kuck

Director, TMT Strategy, KPMG US

+1 571-389-4238

As technology executives position their companies to weather the COVID-19 storm, the initial focus is to assess and monitor the health of distribution partners and end customers and provide short-term support to those with lower resilience to withstand the turmoil.

But as the economy begins to reopen, companies have an opportunity to holistically re-evaluate the route-to-market (RTM) mix underpinning their growth strategies. A new KPMG report, Optimizing routes-to-market to accelerate COVID-19 recovery, shows how tech executives can best extend targeted triage support and effectively manage RTM channels with data and analytics to allow their companies to emerge better equipped to capture future growth.

Optimizing routes-to-market to accelerate COVID-19 recovery
Learn how can tech firms optimize routes-to-market to accelerate COVID-19 recovery.